201. アンジェルマン症候群 Angelman syndrome Clinical trials / Disease details

臨床試験数 : 25 / 薬物数 : 40 - (DrugBank : 11) / 標的遺伝子数 : 22 - 標的パスウェイ数 : 20

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05127226 (ClinicalTrials.gov)	December 22, 2021	9/11/2021	HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Dos ...	HALOS: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intrat ...	Angelman Syndrome	Drug: ION582	Ionis Pharmaceuticals, Inc.	Biogen	Recruiting	2 Years	50 Years	All	44	Phase 1/Phase 2	United States;Australia;Israel;United Kingdom

First Previous1Next Last